Microsatellite instability in hematological malignancies: Hypermutation vs. immune control-who is challenging who?

about

Classification of current anticancer immunotherapies Trial watch: Naked and vectored DNA-based anticancer vaccines

P2860

Q35149637-CD850F62-2707-40DD-A4EA-E1F10E854D9E Q35798986-11F594F4-3A42-43D0-B76F-677502D75446

P2860

Microsatellite instability in hematological malignancies: Hypermutation vs. immune control-who is challenging who?

Item

http://www.wikidata.org/entity/Q42937984

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Microsatellite instability in ...... ontrol-who is challenging who?

@en

Microsatellite instability in ...... ontrol-who is challenging who?

@nl

type

Item

label

Microsatellite instability in ...... ontrol-who is challenging who?

@en

Microsatellite instability in ...... ontrol-who is challenging who?

@nl

prefLabel

Microsatellite instability in ...... ontrol-who is challenging who?

@en

Microsatellite instability in ...... ontrol-who is challenging who?

@nl

P1476

Microsatellite instability in ...... ontrol-who is challenging who?

@en

P2093

Claudia Maletzki

http://www.w3.org/2001/XMLSchema#string

Michael Linnebacher

http://www.w3.org/2001/XMLSchema#string

Saskia Stier

http://www.w3.org/2001/XMLSchema#string

P2860

Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases

An MSI tumor specific frameshift mutation in a coding microsatellite of MSH3 encodes for HLA-A0201-restricted CD8+ cytotoxic T cell epitopes

Thiopurines, DNA damage, DNA repair and therapy-related cancer.

DNA damage and repair in human cancer: molecular mechanisms and contribution to therapy-related leukemias.

Frameshift-derived neoantigens constitute immunotherapeutic targets for patients with microsatellite-instable haematological malignancies: frameshift peptides for treating MSI+ blood cancers.

Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers.

Immunogenic peptides generated by frameshift mutations in DNA mismatch repair-deficient cancer cells.

Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation.

Microsatellite instability indicative of defects in the major mismatch repair genes is rare in patients with B-cell chronic lymphocytic leukemia: Evaluation with disease stage and family history

P304

e25419

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/ONCI.25419

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258118138

http://www.w3.org/2001/XMLSchema#string

P698

24167765

http://www.w3.org/2001/XMLSchema#string

P921

microsatellite

P932

3805632

http://www.w3.org/2001/XMLSchema#string

Microsatellite instability in hematological malignancies: Hypermutation vs. immune control-who is challenging who?

about

P2860

P2860

Microsatellite instability in hematological malignancies: Hypermutation vs. immune control-who is challenging who?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932